Cargando…
Single-dose AAV vector gene immunotherapy to treat food allergy
Immunotherapies for patients with food allergy have shown some success in limiting allergic responses. However, these approaches require lengthy protocols with repeated allergen dosing and patients can relapse following discontinuation of treatment. The purpose of this study was to test if a single...
Autores principales: | Gonzalez-Visiedo, Miguel, Li, Xin, Munoz-Melero, Maite, Kulis, Michael D., Daniell, Henry, Markusic, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361215/ https://www.ncbi.nlm.nih.gov/pubmed/35990748 http://dx.doi.org/10.1016/j.omtm.2022.07.008 |
Ejemplares similares
-
Immune Response Mechanisms against AAV Vectors in Animal Models
por: Martino, Ashley T., et al.
Publicado: (2019) -
Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016) -
Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018) -
Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023) -
Feasibility of sustained response through long-term dosing in food allergy immunotherapy
por: Andorf, Sandra, et al.
Publicado: (2017)